Covered recipient · General Payments record
ASHLEY NICOLE GONIEA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,001.33
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.23 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $238.97 | 9 |
| Novo Nordisk AS | $61.70 | 3 |
| PFIZER INC. | $40.87 | 2 |
| Lilly USA, LLC | $30.54 | 2 |
| Xeris Pharmaceuticals, Inc. | $23.48 | 1 |
| ITI, Inc. | $21.40 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.06 | 1 |
| Acerta Pharma LLC | $18.73 | 1 |
| Medtronic, Inc. | $18.55 | 1 |
| Amgen Inc. | $17.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.00 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233562 | CMS |
| ABBVIE INC. | $10.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233564 | CMS |
| ABBVIE INC. | $10.00 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233566 | CMS |
| ABBVIE INC. | $31.51 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233568 | CMS |
| ABBVIE INC. | $8.75 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233570 | CMS |
| ABBVIE INC. | $102.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233572 | CMS |
| ABBVIE INC. | $10.00 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233574 | CMS |
| ABBVIE INC. | $30.80 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233576 | CMS |
| ABBVIE INC. | $25.25 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107233578 | CMS |
| Amgen Inc. | $17.93 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117564494 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.73 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104713821 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.40 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143465715 | CMS |
| Lilly USA, LLC | $14.39 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135596046 | CMS |
| Lilly USA, LLC | $16.15 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135596048 | CMS |
| Medtronic, Inc. | $18.55 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117002160 | CMS |
| Novo Nordisk Inc | $15.01 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100555543 | CMS |
| Novo Nordisk Inc | $21.86 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100263948 | CMS |
| Novo Nordisk Inc | $24.83 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100302017 | CMS |
| PFIZER INC. | $18.09 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131953182 | CMS |
| PFIZER INC. | $22.78 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131090384 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $21.06 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153624027 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.48 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144620933 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.